A Simple Composite Metric for the Assessment of Glycemic Status from Continuous Glucose Monitoring Data: Implications for Clinical Practice and the Artificial Pancreas

被引:27
作者
Hirsch, Irl B. [1 ]
Balo, Andrew K. [2 ]
Sayer, Kevin [2 ]
Garcia, Arturo [2 ]
Buckingham, Bruce A. [3 ]
Peyser, Thomas A.
机构
[1] Univ Washington, Seattle, WA 98195 USA
[2] Dexcom Inc, 6340 Sequence Dr, San Diego, CA 92121 USA
[3] Stanford Univ, Stanford, CA 94305 USA
关键词
Glycemic state; Glycemic variability; Continuous glucose monitoring; Composite metric; Artificial pancreas; TYPE-1; VARIABILITY; QUALITY; ADULTS;
D O I
10.1089/dia.2017.0080
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The potential clinical benefits of continuous glucose monitoring (CGM) have been recognized for many years, but CGM is used by a small fraction of patients with diabetes. One obstacle to greater use of the technology is the lack of simplified tools for assessing glycemic control from CGM data without complicated visual displays of data. Methods: We developed a simple new metric, the personal glycemic state (PGS), to assess glycemic control solely from continuous glucose monitoring data. PGS is a composite index that assesses four domains of glycemic control: mean glucose, glycemic variability, time in range and frequency and severity of hypoglycemia. The metric was applied to data from six clinical studies for the G4 Platinum continuous glucose monitoring system (Dexcom, San Diego, CA). The PGS was also applied to data from a study of artificial pancreas comparing results from open loop and closed loop in adolescents and in adults. Results: The new metric for glycemic control, PGS, was able to characterize the quality of glycemic control in a wide range of study subjects with various mean glucose, minimal, moderate, and excessive glycemic variability and subjects on open loop versus closed loop control. Conclusion: A new composite metric for the assessment of glycemic control based on CGM data has been defined for use in assessing glycemic control in clinical practice and research settings. The new metric may help rapidly identify problems in glycemic control and may assist with optimizing diabetes therapy during timeconstrained physician office visits.
引用
收藏
页码:S38 / S48
页数:11
相关论文
共 29 条
[1]  
[Anonymous], DIABETES TECHN UNPUB
[2]  
[Anonymous], FDA EXP IND CONT GLU
[3]  
[Anonymous], JAMA J AM MED ASSOC
[4]  
APGAR V, 1953, Curr Res Anesth Analg, V32, P260
[5]  
Bartelme Amanda, 2009, J Diabetes Sci Technol, V3, P992
[6]   Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections The DIAMOND Randomized Clinical Trial [J].
Beck, Roy W. ;
Riddlesworth, Tonya ;
Ruedy, Katrina ;
Ahmann, Andrew ;
Bergenstal, Richard ;
Haller, Stacie ;
Kollman, Craig ;
Kruger, Davida ;
McGill, Janet B. ;
Polonsky, William ;
Toschi, Elena ;
Wolpert, Howard ;
Price, David .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (04) :371-378
[7]  
Bergenstal Richard M, 2013, J Diabetes Sci Technol, V7, P562
[8]   Statistical Tools to Analyze Continuous Glucose Monitor Data [J].
Clarke, William ;
Kovatchev, Boris .
DIABETES TECHNOLOGY & THERAPEUTICS, 2009, 11 :S45-S54
[9]   Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring [J].
Deis, Dorothee ;
Bolinder, Jan ;
Riveline, Jean-Pierre ;
Battelino, Tadej ;
Bosi, Emanuele ;
Tubiana-Rufi, Nadia ;
Kerr, David ;
Phillip, Moshe .
DIABETES CARE, 2006, 29 (12) :2730-2732
[10]   Closed- Loop Artificial Pancreas Systems: Engineering the Algorithms [J].
Doyle, Francis J., III ;
Huyett, Lauren M. ;
Lee, Joon Bok ;
Zisser, Howard C. ;
Dassau, Eyal .
DIABETES CARE, 2014, 37 (05) :1191-1197